TaiwanJ Pharmaceuticals Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was TWD 0 compared to TWD 61.720 million a year ago. Operating loss was TWD 19.522 million compared to operating Income of TWD 32.674 million a year ago. Net loss was TWD 22.121 million compared to net income of TWD 23.428 million a year ago. Basic loss per share was TWD 0.32 compared to basic earnings per share of TWD 0.34 a year ago.